MyFinsight
Home
Blog
About
Contact
Download
Download image
Net (decrease)
increase in cash
-$1,313,203
Accrued expenses
$574,502
Stock-based compensation
$198,530
Amortization of loan
commitment fee
$17,439
Net cash used in
operating activities
-$1,313,203
Canceled cashflow
$790,471
Net loss
-$1,999,397
Accounts payable
-$52,677
Grant receivable
-$46,958
Prepaid expenses
$4,642
Back
Back
Cash Flow
source: myfinsight.com
Anebulo Pharmaceuticals, Inc. (ANEB)
Anebulo Pharmaceuticals, Inc. (ANEB)